科弈药业超21亿美元CAR-T授权;赛诺菲达成16亿美元并购...上周交易有哪些亮点?| 一周交易

创鉴汇
31 Jul

据创鉴汇不完全统计,7月21日至7月27日全球生物制药领域共披露16起交易事件,潜在交易总额超56.5亿美元。交易标的涉及单克隆抗体、基因编辑、CAR-T细胞疗法、疫苗、核药及共价剂等多个领域。其中,科弈药业与美国ERIGEN公司达成双靶向CAR-T疗法KQ-2003的独家海外授权许可协议,成为上周最引人注目的交易之一。科弈药业将获得总金额21.35亿美元,包括1500万美元近期开发里程碑付款。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10